Health Canada approves Pfizer’s new bivalent COVID-19 vaccine – CBC

    You can use your smart phone to browse stories in the comfort of your hand. Simply browse this site on your smart phone.

    Using an RSS Reader you can access most recent stories and other feeds posted on this network.

    SNetwork Recent Stories

Health Canada approves Pfizer’s new bivalent COVID-19 vaccine – CBC

by pmnationtalk on October 7, 2022128 Views

Oct 07, 2022

It is the 2nd combination vaccine cleared by the ministry

Health Canada has approved Pfizer’s new bivalent COVID-19 vaccine, which targets the virus strains now most common in Canada.

The updated version of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targets the Omicron BA.4 and BA.5 subvariants, as well as the original strain of the virus, and is authorized for use as a booster dose in people 12 years of age and older.

“The booster is expected to trigger a strong immune response against both the original SARS-CoV-2 strain as well as the Omicron BA.4/BA.5 subvariants,” Health Canada said in a media statement.

“It is expected to have a similar safety profile to the original Pfizer-BioNTech Comirnaty vaccine, with mostly mild side effects.”

Read More: https://www.cbc.ca/news/politics/pfizer-bivalent-covid-vaccine-approved-1.6609699

Send To Friend Email Print Story

Comments are closed.

NationTalk Partners & Sponsors Learn More

CLOSE
CLOSE